539 related articles for article (PubMed ID: 15541629)
21. Adverse behavioral effects in individuals with mental retardation and mood disorders treated with carbamazepine.
Friedman DL; Kastner T; Plummer AT; Ruiz MQ; Henning D
Am J Ment Retard; 1992 Mar; 96(5):541-6. PubMed ID: 1562312
[TBL] [Abstract][Full Text] [Related]
22. Use of psychotropic medication in Oklahoma: a statewide survey.
Spreat S; Conroy JW; Jones JC
Am J Ment Retard; 1997 Jul; 102(1):80-5. PubMed ID: 9241410
[TBL] [Abstract][Full Text] [Related]
23. Behavioral problems and medication utilization.
Harper DC; Wadsworth JS
Ment Retard; 1993 Apr; 31(2):97-103. PubMed ID: 8479337
[TBL] [Abstract][Full Text] [Related]
24. Substituting traditional antipsychotics with risperidone for individuals with mental retardation.
Simon EW; Blubaugh KM; Pippidis M
Ment Retard; 1996 Dec; 34(6):359-66. PubMed ID: 8990820
[TBL] [Abstract][Full Text] [Related]
25. Psychotropic drug prescription in Italy. A survey in general practice.
Bellantuono C; Arreghini E; Adami M; Bodini F; Gastaldo M; Micciolo R
Soc Psychiatry Psychiatr Epidemiol; 1989 Jul; 24(4):212-8. PubMed ID: 2502864
[TBL] [Abstract][Full Text] [Related]
26. National trends in the outpatient treatment of children and adolescents with antipsychotic drugs.
Olfson M; Blanco C; Liu L; Moreno C; Laje G
Arch Gen Psychiatry; 2006 Jun; 63(6):679-85. PubMed ID: 16754841
[TBL] [Abstract][Full Text] [Related]
27. Prescription of psychotropic drugs in adolescent psychiatry wards in Finland.
Haapasalo-Pesu KM; Erkolahti R; Saarijärvi S; Aalberg V
Nord J Psychiatry; 2004; 58(3):213-8. PubMed ID: 15204208
[TBL] [Abstract][Full Text] [Related]
28. Medication and programming in controlling the behavior of mentally retarded individuals in community settings.
Schalock RL; Foley JW; Toulouse A; Stark JA
Am J Ment Defic; 1985 Mar; 89(5):503-9. PubMed ID: 2859807
[TBL] [Abstract][Full Text] [Related]
29. Pilot study on the use of psychotropic medication in persons with mental retardation.
Radouco-Thomas M; Bolduc M; Brisson A; Brassard P; Fortier L; Thivierge J
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Aug; 28(5):879-83. PubMed ID: 15363610
[TBL] [Abstract][Full Text] [Related]
30. Tardive dyskinesia and intellectual disability: an examination of demographics and topography in adults with dual diagnosis and atypical antipsychotic use.
Fodstad JC; Bamburg JW; Matson JL; Mahan S; Hess JA; Neal D; Holloway J
Res Dev Disabil; 2010; 31(3):750-9. PubMed ID: 20207106
[TBL] [Abstract][Full Text] [Related]
31. Rational use and rationale for use: psychiatric medication at an Argentine institution for intellectual disability.
de Menil V; Cohen A
Transcult Psychiatry; 2009 Dec; 46(4):651-71. PubMed ID: 20028682
[TBL] [Abstract][Full Text] [Related]
32. Psychotropic drug use in intellectually disabled group-home residents with behavioural problems.
Stolker JJ; Koedoot PJ; Heerdink ER; Leufkens HG; Nolen WA
Pharmacopsychiatry; 2002 Jan; 35(1):19-23. PubMed ID: 11819154
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of psychoactive drug use among North Dakota group home residents.
Burd L; Fisher W; Vesely BN; Williams M; Kerbeshian J; Leech C
Am J Ment Retard; 1991 Sep; 96(2):119-26. PubMed ID: 1930945
[TBL] [Abstract][Full Text] [Related]
34. [Use of psychotropic drugs in mentally handicapped adults].
Meins W
Psychiatr Prax; 1988 Nov; 15(6):218-22. PubMed ID: 3237896
[TBL] [Abstract][Full Text] [Related]
35. Psychotropic medication for behaviour problems in people with intellectual disability: a review of the current literature.
Deb S; Unwin GL
Curr Opin Psychiatry; 2007 Sep; 20(5):461-6. PubMed ID: 17762588
[TBL] [Abstract][Full Text] [Related]
36. [Psychotropic drug use and correspondence with psychiatric diagnoses in the mental health in the general population survey].
Grolleau A; Cougnard A; Bégaud B; Verdoux H
Encephale; 2008 Sep; 34(4):352-9. PubMed ID: 18922237
[TBL] [Abstract][Full Text] [Related]
37. Practitioner review: Psychopharmacology in children and adolescents with mental retardation.
Handen BL; Gilchrist R
J Child Psychol Psychiatry; 2006 Sep; 47(9):871-82. PubMed ID: 16930381
[TBL] [Abstract][Full Text] [Related]
38. Psychoactive drug use in an institution for intellectually handicapped persons.
Sachdev PS
Med J Aust; 1991 Jul; 155(2):75-9. PubMed ID: 1677447
[TBL] [Abstract][Full Text] [Related]
39. Psychotropic medication use for challenging behaviors in persons with intellectual disabilities: an overview.
Matson JL; Neal D
Res Dev Disabil; 2009; 30(3):572-86. PubMed ID: 18845418
[TBL] [Abstract][Full Text] [Related]
40. The prescription of psychotropic drugs in psychiatric residential facilities: a national survey in Italy.
Tomasi R; de Girolamo G; Santone G; Picardi A; Micciolo R; Semisa D; Fava S;
Acta Psychiatr Scand; 2006 Mar; 113(3):212-23. PubMed ID: 16466405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
